Physician

Benjamin B.a. Bakall, M.D., PH.D.

According to 2025 Medicare claims, Benjamin Bakall, M.D., PH.D. (NPI: 1700085222) practices ophthalmology in the Phoenix-Mesa-Chandler, AZ market, with the plurality of this provider's patient population coming from Maricopa, AZ. This provider's primary affiliated billing organization is ASSOCIATED RETINA CONSULTANTS, LTD. (NPI: 1164633160; TIN: 860285158) and primary practice location at 85381-3690. Bakall is affiliated with the Innovation Care Partners MSSP (ACO ID: A2029), participating under the MSSP model.

Bakall's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,109 traditional Medicare patients, billed 31,488 HCPCS/CPT codes, and received $2,555,827 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 939 prescription claims across 288 beneficiaries totaling $34,147 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 67 records totaling $74,314. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,034,492 to $2,555,827. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $18,995 to $34,147. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.